CX Institutional

Position in VTRS — Viatris Inc

CIK 1737089 AUBURN, IN

Position in VTRS

as of Jun 30, 2026 · filed Jul 2, 2026 Compact

Position Value

$301,386

+$49,749 QoQ

Shares Held

18,979

+1.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#484

of 1,016 holders

Holding Since

Dec 2020

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CX Institutional holds $883,704 across 7 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (34.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	6,271	$450,634
2	VTRS	Viatris Inc This page	18,979	$301,386
3	TEVA	Teva Pharmaceutical Industries Ltd	1,600	$54,208
4	AMPH	Amphastar Pharmaceuticals, Inc.	1,259	$25,406
5	NBIX	Neurocrine Biosciences Inc	126	$21,236
6	UTHR	UNITED THERAPEUTICS Corp	39	$21,131
7	HLN	Haleon plc	1,040	$9,703

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$301,386	18,979	+1.9%	Shares	Sole	2026-07-02
2026-03-31	$251,637	18,626	-0.2%	Shares	Sole	2026-04-06
2025-12-31	$232,304	18,659	+53.6%	Shares	Sole	2026-02-02
2025-09-30	$120,245	12,146	+67.1%	Shares	Sole	2025-10-23
2025-03-31	$63,321	7,270	-43.6%	Shares	Sole	2025-04-15
2024-12-31	$160,542	12,895	+3.7%	Shares	Sole	2025-01-21
2024-09-30	$144,393	12,437	+3.6%	Shares	Sole	2024-10-11
2024-06-30	$127,613	12,005	+0.5%	Shares	Sole	2024-07-11
2024-03-31	$142,563	11,940	-1.2%	Shares	Sole	2024-04-15
2023-12-31	$130,934	12,090	-96.4%	Shares	Sole	2024-01-12
2023-06-30	$3,354,397	336,112	+5.2%	Shares	Sole	2023-07-26
2023-03-31	$3,073,743	319,516	+22738.9%	Shares	Sole	2023-05-04
2022-06-30	$14,647	1,399	+126.0%	Shares	Sole	2022-08-02
2021-09-30	$8,387	619	-24.5%	Shares	Sole	2021-11-10
2021-06-30	$11,717	820	+90.3%	Shares	Sole	2021-08-04
2021-03-31	$6,021	431	-5.5%	Shares	Sole	2021-04-15
2020-12-31	$8,545	456	—	Shares	Sole	2021-01-12
No filing history on record for this holder in this stock.